Insider Transactions in Q3 2021 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 27
2021
|
Douglas J. Hughes Director |
BUY
Open market or private purchase
|
Direct |
18,247
+23.79%
|
$145,976
$8.24 P/Share
|
|
Aug 20
2021
|
George V Migausky Director |
BUY
Open market or private purchase
|
Direct |
7,000
+9.43%
|
$49,000
$7.65 P/Share
|
|
Aug 13
2021
|
Atul Pande Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+9.96%
|
$35,000
$7.98 P/Share
|
|
Aug 10
2021
|
Andrew J. Fromkin Director |
BUY
Open market or private purchase
|
Direct |
5,500
+10.74%
|
$38,500
$7.9 P/Share
|
|
Aug 03
2021
|
Peter Salzmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
570,613
+44.8%
|
-
|
|
Aug 03
2021
|
Julia G. Butchko Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
285,306
+45.28%
|
-
|
|
Aug 02
2021
|
Roivant Sciences Ltd. |
BUY
Other acquisition or disposition
|
Direct |
17,021,276
+18.83%
|
-
|